2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Sell
23
UNCHF Quote, Financials, Valuation and Earnings
Last price:
$7.63
Seasonality move
:
1.52%
Day range:
$7.63 - $8.24
52-week range:
$6.96 - $12.67
Dividend yield:
1.21%
P/E ratio:
22.72x
P/S ratio:
2.08x
P/B ratio:
2.64x
Volume:
7.5K
Avg. volume:
23.1K
1-year change:
-25.65%
Market cap:
$13.3B
Revenue:
$6.5B
EPS (TTM):
$0.34
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Unicharm has -- downside to fair value with a price target of -- per share.
UNCHF vs. S&P 500
-
Over the past 5 trading days, Unicharm has underperformed the S&P 500 by -1.46% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Unicharm does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Unicharm revenues have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter Unicharm reported revenues of $1.5B.
Earnings Growth
-
Unicharm earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Unicharm reported earnings per share of $0.09.
Enterprise value:
11.8B
EV / Invested capital:
2.02x
Price / LTM sales:
2.08x
EV / EBIT:
11.96x
EV / Revenue:
1.84x
PEG ratio (5yr expected):
2.49x
EV / Free cash flow:
15.83x
Price / Operating cash flow:
17.92x
Enterprise value / EBITDA:
9.13x
Gross Profit (TTM):
$2.5B
Return On Assets:
7.66%
Net Income Margin (TTM):
9.24%
Return On Equity:
10.94%
Return On Invested Capital:
10.58%
Operating Margin:
15.27%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $6.8B | $6.6B | $6.4B | $1.6B | $1.5B | |
| Gross Profit | $2.4B | $2.5B | $2.5B | $621.2M | $580.8M | |
| Operating Income | $839.2M | $967.2M | $927M | $252.3M | $227.8M | |
| EBITDA | $1.2B | $1.3B | $1.3B | $342.2M | $322.4M | |
| Diluted EPS | $0.28 | $0.34 | $0.34 | $0.07 | $0.09 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.5B | $4.8B | $4.3B | $4.2B | $4.2B | |
| Total Assets | $8.3B | $8.4B | $7.9B | $7.7B | $7.9B | |
| Current Liabilities | $2B | $2.2B | $1.8B | $1.7B | $1.8B | |
| Total Liabilities | $2.9B | $2.9B | $2.5B | $2.2B | $2.3B | |
| Total Equity | $5.4B | $5.5B | $5.4B | $5.4B | $5.7B | |
| Total Debt | $332.1M | $359.8M | $218.3M | $177.6M | $166.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $821.4M | $1.1B | $1B | $284.7M | $186.5M | |
| Cash From Investing | -$370.7M | -$800.6M | -$40M | -$535.8M | $213.6M | |
| Cash From Financing | -$512M | -$501.1M | -$508.4M | -$126M | -$178.3M | |
| Free Cash Flow | $568.7M | $819.7M | $746.8M | $203.8M | $136.1M | |
UNCHF
Sector
Market Cap
$13.3B
$258.9M
Price % of 52-Week High
60.22%
75.55%
Dividend Yield
1.21%
0%
Shareholder Yield
2.62%
2.89%
1-Year Price Total Return
-25.65%
-11.52%
Beta (5-Year)
0.325
0.392
Dividend yield:
1.21%
Annualized payout:
$0.09
Payout ratio:
27.83%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$7.75
200-day SMA
Sell
Level
$9.09
Bollinger Bands (100)
Sell
Level
7.42 - 8.62
Chaikin Money Flow
Sell
Level
-2.3M
20-day SMA
Sell
Level
$8.15
Relative Strength Index (RSI14)
Sell
Level
42.91
ADX Line
Buy
Level
15.72
Williams %R
Neutral
Level
-75.5102
50-day SMA
Sell
Level
$8.31
MACD (12, 26)
Sell
Level
-0.24
25-day Aroon Oscillator
Sell
Level
-52
On Balance Volume
Neutral
Level
485.5K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.8437)
Buy
CA Score
(Annual)
Level (0.9415)
Buy
Beneish M-Score
(Annual)
Level (-2.775)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-2.8339)
Buy
Piotroski F Score
(Annual)
Level (6)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Focusing on personal hygiene products utilizing non-woven fabric, Unicharm is the largest manufacturer of disposable baby diapers, feminine sanitary, and adult incontinence products in Japan and Asia. Its personal-care business accounted for 86% of its sales as of 2021, with the balance from mainly the pet care. Unicharm generates 62% sales from overseas, of which nearly three quarters of sales are from Asia, mostly China, Indonesia and Thailand. India, followed by Vietnam, is the fastest rising market. Outside Asia, it also operates in Saudi Arabia, Americas and Europe. Drugstores, supermarkets, baby product specialty stores as well as e-commerce are the key sales channels.
Stock Forecast FAQ
In the current month, UNCHF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The UNCHF average analyst price target in the past 3 months is --.
-
Where Will Unicharm Stock Be In 1 Year?
According to analysts, the consensus estimate is that Unicharm share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Unicharm?
Analysts are divided on their view about Unicharm share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Unicharm is a Sell and believe this share price will rise from its current level to --.
-
What Is Unicharm's Price Target?
The price target for Unicharm over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is UNCHF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Unicharm is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of UNCHF?
You can purchase shares of Unicharm via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Unicharm shares.
-
What Is The Unicharm Share Price Today?
Unicharm was last trading at $7.63 per share. This represents the most recent stock quote for Unicharm. Yesterday, Unicharm closed at $7.63 per share.
-
How To Buy Unicharm Stock Online?
In order to purchase Unicharm stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Where Will Dell Stock Be in 5 Years?
So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
